Wired: 'Scientists Thought Parkinson’s Was in Our Genes. It Might Be in the Water'
Human Genome Project
Trichlorethylene (TCE)
Human Exposome Project
Link to Human Exposome Project
All told, more than half of Parkinson’s research dollars in the past two decades have flowed toward genetics.
But Parkinson’s rates in the US have doubled in the past 30 years. And studies suggest they will climb another 15 to 35 percent in each coming decade. This is not how an inherited genetic disease is supposed to behave.
“We thought we were going to solve it,” Langston told me. Researchers affiliated with the institute created the first animal model for Parkinson’s, identified a pesticide called Paraquat as a near chemical match to MPTP, and proved that farm workers who sprayed Paraquat developed Parkinson’s at exceedingly high rates. Then they showed that identical twins developed Parkinson’s at the same rate as fraternal twins—something that wouldn’t make sense if the disease were purely genetic, since identical twins share DNA and fraternal twins do not. They even noted TCE as a potential cause of the disease, Langston says.
Human Genome Project
But for Langston and his colleagues, the Human Genome Project sucked the air out of the environmental health space. Genetics became the “800-pound gorilla,” as one scientist put it. “All the research dollars went toward genetics,” says Sam Goldman, who worked with Langston on the twin study. “It’s just a lot sexier than epidemiology. It’s the latest gadget, the bigger rocket.”
“The Human Genome Project was a $3 billion investment, and what did we find out?” says Thomas Hartung, a toxicologist at Johns Hopkins. “Five percent of all disease is purely genetic. Less than 40 percent of diseases even have a genetic component.”
Trichlorethylene (TCE)
For approximately 35 years, Marines and sailors who lived at Lejeune unknowingly breathed in vaporized TCE whenever they turned on their tap. The Navy, which oversees the Marine Corps, first denied the toxic plume’s existence, then refused to admit it could affect Marines’ health.
But as Lejeune’s vets aged, cancers and unexplained illness began stalking them at staggering rates. Marines stationed on base had a 35 percent higher risk of developing kidney cancer, a 47 percent higher risk of Hodgkin’s lymphoma, a 68 percent higher risk of multiple myeloma. At the local cemetery, the section reserved for infants had to be expanded.
When Goldman compared both populations, the results were shocking: Marines exposed to TCE at Lejeune were 70 percent more likely to have Parkinson’s than those stationed at Pendleton. And in a follow-up study last year, he showed that disease progression in Lejeune vets with the highest exposure to TCE was faster than those with low or no exposure, too.
Briana De Miranda has re-created Camp Lejeune in her lab, but for mice. [...] De Miranda’s studies, the first ever on inhaled TCE toxicity and Parkinson’s, are compelling, her colleagues agree, and well designed.
“I think TCE is the most important cause of Parkinson’s in the US,” says Ray Dorsey, the Parkinson’s expert at the University of Rochester.
No one knows exactly how much of the world’s drinking water is laced with TCE. The US Centers for Disease Control and Prevention reckons that the water supply of between 4 and 18 percent of Americans is contaminated, although not always at dangerous concentrations; the Environmental Working Group figures 17 million Americans drink the stuff.
Yet only 1 percent of the roughly 350,000 chemicals in use in the United States have ever been tested for safety. In its 55-year history, the EPA has banned or restricted about a dozen (by contrast, the EU has banned more than 2,000).
Human Exposome Project
[Miller] grew tired of the “whack-a-mole approach” of modern toxicology: identifying one of the 350,000 chemicals on the market as a potential toxicant
He wanted a shotgun approach, an answer to the way genome sequencing identifies all the genes in the body. What Miller wants is a Human Exposome Project. “We realized that this wasn’t just about Parkinson’s,” he says. “There were so many disease states we could look at.” Quantify our exposomes, Miller hopes, and we can know what ails us.
Link to Human Exposome Project